The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Acquired Cancer Resistance Mechanisms

How tumors evolve to escape chemotherapy, targeted drugs, and immunotherapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Acquired Cancer Resistance Mechanisms?

Acquired cancer resistance refers to tumor progression after an initial response to treatment, driven by genetic, epigenetic, and microenvironmental changes that emerge under therapeutic pressure. It is now recognized as the rule rather than the exception in advanced cancer.

Mechanisms include secondary mutations in the drug target, activation of bypass signaling pathways, gene amplification, drug efflux, lineage plasticity such as small-cell transformation in lung cancer, and immune escape via downregulation of HLA or interferon signaling.

Modern oncology relies on serial molecular profiling, including liquid biopsy of circulating tumor DNA, to detect resistance early and select the next therapy. Rational drug combinations and adaptive trial designs aim to delay or prevent resistance.

Symptoms

Initial tumor shrinkage followed by regrowth or new lesions
Rising tumor markers despite ongoing therapy
New imaging changes in previously controlled disease
Need for repeat biopsy or liquid biopsy
Decision point for next-line systemic therapy

Risk Factors

Long duration of single-agent therapy
High initial tumor mutational burden
Insufficient drug exposure or non-adherence
Specific resistance prone tumor types
Microenvironmental immune suppression

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When previously controlled disease begins to progress
  • When tumor markers rise despite therapy
  • When new symptoms suggest spread or transformation
  • Before switching to next-line systemic treatment
  • When clinical trials of resistance-directed agents are open

Treatment Methods

01
Repeat tissue biopsy at progression
02
Liquid biopsy for circulating tumor DNA mutations
03
Switch to drug active against resistance mutations
04
Combination therapy targeting bypass pathways
05
Re-challenge after a drug holiday in selected cases
06
Enrollment in resistance-targeted clinical trials
07
Multidisciplinary discussion of palliative options

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.